|
Sofosbuvir impurity D
|
S658889-5mg
|
|
N/A |
5mg
|
¥ 35000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Sofosbuvir impurity D
|
S658889-1mg
|
|
N/A |
1mg
|
¥ 15000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Sofosbuvir impurity H
|
S658888-5mg
|
|
N/A |
5mg
|
¥ 35000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Sofosbuvir impurity H
|
S658888-1mg
|
|
N/A |
1mg
|
¥ 15000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
STING agonist-3 trihydrochloride
|
S658883-5mg
|
≥98% |
N/A |
5mg
|
¥ 4000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
STING agonist-3 trihydrochloride
|
S658883-10mg
|
≥98% |
N/A |
10mg
|
¥ 7000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Sofosbuvir impurity L
|
S658878-5mg
|
|
N/A |
5mg
|
¥ 35000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Sofosbuvir impurity L
|
S658878-1mg
|
|
N/A |
1mg
|
¥ 15000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SM-433 hydrochloride
|
S658876-5mg
|
≥98% |
N/A |
5mg
|
¥ 5900.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SM-433 hydrochloride
|
S658876-1mg
|
≥98% |
N/A |
1mg
|
¥ 2200.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SM-433 hydrochloride
|
S658876-10mg
|
≥98% |
N/A |
10mg
|
¥ 9500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SJ995973
|
S658850-5mg
|
≥98% |
N/A |
5mg
|
¥ 8500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SJ995973
|
S658850-1mg
|
≥98% |
N/A |
1mg
|
¥ 2800.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SJ995973
|
S658850-10mg
|
≥98% |
N/A |
10mg
|
¥ 14500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Syk-IN-4
|
S658845-5mg
|
≥98% |
N/A |
5mg
|
¥ 5000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Syk-IN-4
|
S658845-50mg
|
≥98% |
N/A |
50mg
|
¥ 30000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Syk-IN-4
|
S658845-25mg
|
≥98% |
N/A |
25mg
|
¥ 18000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Syk-IN-4
|
S658845-10mg
|
≥98% |
N/A |
10mg
|
¥ 8500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Syk-IN-4
|
S658845-100mg
|
≥98% |
N/A |
100mg
|
¥ 46000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SNIPER(TACC3)-2
|
S658839-5mg
|
≥99% |
N/A |
5mg
|
¥ 6220.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SNIPER(TACC3)-2
|
S658839-10mg
|
≥99% |
N/A |
10mg
|
¥ 9330.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SG-094
|
S658832-5mg
|
≥95% |
N/A |
5mg
|
¥ 1800.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SG-094
|
S658832-50mg
|
≥95% |
N/A |
50mg
|
¥ 9000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SG-094
|
S658832-25mg
|
≥95% |
N/A |
25mg
|
¥ 5600.9
|
期货,请咨询 |
|
0 |
阿拉丁 |